Blueprint Medicines Ownership | Who Owns Blueprint Medicines?

Overview Forecast RevenueFinancials Chart Transcripts

Blueprint Medicines Ownership Summary

Blueprint Medicines is owned by 101.98% institutional investors, 0.90% insiders. Blackrock is the largest institutional shareholder, holding 10.58% of BPMC shares. Vanguard Health Care Inv is the top mutual fund, with 3.29% of its assets in Blueprint Medicines shares.

BPMC Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Blueprint Medicines	101.98%	0.90%	-2.89%
Sector	Healthcare Stocks	88.01%	8.90%	3.09%
Industry	Biotech Stocks	109.70%	8.77%	-18.47%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	6.65M	10.58%	$716.45M
Vanguard group	6.54M	10.40%	$704.72M
Price t rowe associates inc /md/	5.87M	9.34%	$633.03M
Fmr	4.83M	7.69%	$520.97M
Wellington management group llp	3.24M	5.15%	$348.73M
State street	2.38M	3.79%	$256.50M
William blair investment management	1.59M	2.54%	$171.79M
Geode capital management	1.46M	2.32%	$157.33M
Macquarie group	1.31M	2.09%	$141.41M
Jpmorgan chase	1.22M	1.95%	$131.99M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Aquilo capital management	114.60K	11.91%	$12.35M
Ally bridge group (ny)	75.64K	4.86%	$8.15M
Orion investment	108.79K	4.67%	$11.73M
Integral health asset management	340.00K	3.48%	$36.65M
First turn management	184.90K	3.24%	$19.93M
Dafna capital management	104.76K	2.70%	$11.29M
Casdin capital	326.38K	2.69%	$35.18M
Avidity partners management lp	383.00K	1.75%	$41.28M
Emerald mutual fund advisers trust	278.33K	1.57%	$30.00M
Emerald advisers	341.20K	1.54%	$36.77M

Top Buyers

Holder	Shares	% Assets	Change
Norges bank	592.13K	0.01%	592.13K
1832 asset management	502.65K	0.04%	502.40K
Jennison associates	360.21K	0.02%	360.21K
Vanguard group	6.54M	0.01%	228.49K
Holocene advisors, lp	943.46K	0.42%	228.16K

Top Sellers

Holder	Shares	% Assets	Change
Wellington management group llp	3.24M	0.06%	-939.60K
Pictet asset management sa	1.13M	0.14%	-737.24K
Morgan stanley	421.26K	0.00%	-637.43K
Point72 asset management	-	-	-501.58K
Price t rowe associates inc /md/	5.87M	0.08%	-377.43K

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	592.13K	0.01%	592.13K	$63.82M
Jennison associates	360.21K	0.02%	360.21K	$31.42M
Clearbridge investments	220.98K	0.02%	220.98K	$23.82M
First turn management	184.90K	3.24%	184.90K	$19.93M
Massachusetts financial services co /ma/	169.54K	0.01%	169.54K	$18.27M

Sold Out

Holder	Change
Financial gravity asset management	-4.00
Rakuten securities	-5.00
Innealta capital	-6.00
Hollencrest capital management	-30.00
Stephens consulting	-33.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	339	3.04%	64,638,237	-2.28%	101	0.92%	196	17.37%	83	-17.82%
Jun 30, 2024	329	7.17%	66,148,228	1.60%	105	0.94%	167	8.44%	101	9.78%
Mar 31, 2024	307	9.64%	65,103,888	1.92%	105	0.95%	154	22.22%	92	-3.16%
Dec 31, 2023	280	19.66%	63,876,902	-0.34%	105	0.95%	126	5.88%	95	63.79%
Sep 30, 2023	234	-	64,096,311	0.45%	105	0.95%	119	13.33%	58	-23.68%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Health Care Inv	2.09M	3.29%	285.60K
T. Rowe Price New Horizons	2.05M	3.23%	-
US Small-Cap Growth II Equity Comp	2.05M	3.23%	-12.67K
Vanguard Total Stock Mkt Idx Inv	1.98M	3.12%	2.03K
iShares Russell 2000 ETF	1.73M	2.72%	-262.00
T. Rowe Price Health Sciences	1.67M	2.63%	-50.03K
Vanguard Small Cap Index	1.62M	2.55%	19.61K
SPDR® S&P Biotech ETF	968.02K	1.52%	-3.59K
Vanguard Institutional Extnd Mkt Idx Tr	966.76K	1.52%	19.05K
Vanguard Small Cap Growth Index Inv	917.69K	1.44%	38.73K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 21, 2025	Haviland Kate	CHIEF EXECUTIVE OFFICER	Sell	$159.41K
Jan 21, 2025	Rossi Christina	CHIEF OPERATING OFFICER	Sell	$57.66K
Jan 21, 2025	Rossi Christina	CHIEF OPERATING OFFICER	Sell	$89.76K
Jan 21, 2025	Rossi Christina	CHIEF OPERATING OFFICER	Sell	$89.51K
Jan 21, 2025	Rossi Christina	CHIEF OPERATING OFFICER	Sell	$13.53K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	10
2024 Q4	-	18
2024 Q3	-	6
2024 Q2	-	21
2024 Q1	-	35

BPMC Ownership FAQ

Who Owns Blueprint Medicines?

Blueprint Medicines shareholders are primarily institutional investors at 101.98%, followed by 0.90% insiders and -2.88% retail investors. The average institutional ownership in Blueprint Medicines's industry, Biotech Stocks , is 109.70%, which Blueprint Medicines falls below.

Who owns the most shares of Blueprint Medicines?

Blueprint Medicines’s largest shareholders are Blackrock (6.65M shares, 10.58%), Vanguard group (6.54M shares, 10.40%), and Price t rowe associates inc /md/ (5.87M shares, 9.34%). Together, they hold 30.32% of Blueprint Medicines’s total shares outstanding.

Does Blackrock own Blueprint Medicines?

Yes, BlackRock owns 10.58% of Blueprint Medicines, totaling 6.65M shares as of Jun 2024. This represents 0.02% of BlackRock's total assets, with a market value of 716.45M$. In the last quarter, BlackRock increased its holdings by 199.84K shares, a 3.10% change.

Who is Blueprint Medicines’s biggest shareholder by percentage of total assets invested?

Aquilo capital management is Blueprint Medicines’s biggest shareholder by percentage of total assets invested, with 11.91% of its assets in 114.6K Blueprint Medicines shares, valued at 12.35M$.

Who is the top mutual fund holder of Blueprint Medicines shares?

Vanguard Health Care Inv is the top mutual fund holder of Blueprint Medicines shares, with 3.29% of its total shares outstanding invested in 2.09M Blueprint Medicines shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools